---
schema_version: "secwatch.filing_event.v1"
accession: "0000882095-21-000024"
form_type: "8-K"
ticker: "GILD"
cik: "0000882095"
company_name: "GILEAD SCIENCES, INC."
filed_at: "2021-10-28T23:59:59+00:00"
generated_at: "2026-06-28T17:08:55.647880+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Gilead Q3 GAAP EPS $2.05, revenue $7.4B; Biktarvy record $2.3B; raises FY guidance; redeems $1B notes

## Summary
- GAAP diluted EPS $2.05 vs $0.29 YoY; non-GAAP diluted EPS $2.65 vs $2.11 YoY.
- Total Q3 revenue $7.4B (+13% YoY); product sales ex-Veklury $5.4B (-3% YoY).
- Biktarvy sales record $2.3B (+20% YoY); Veklury sales $1.9B.
- FY 2021 guidance raised: total product sales $26.0-26.3B; non-GAAP EPS $7.90-8.10.
- Called $1B of 2023 notes (Floating Rate and 0.750% Senior Notes) for redemption on Nov 8, 2021.

## SEC filing metadata
- accession: 0000882095-21-000024
- form_type: 8-K
- ticker: GILD
- cik: 0000882095
- company_name: GILEAD SCIENCES, INC.
- filed_at: 2021-10-28T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/882095/000088209521000024/0000882095-21-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/882095/000088209521000024/gild-20211028.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000882095-21-000024
- JSON: https://secwatch.observer/filing/0000882095-21-000024.json
- Plain text: https://secwatch.observer/filing/0000882095-21-000024.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.